DEAN SHANDY: Open Payments
NPI 1356786198 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 12 payments from 5 companies in 2025. Trend: 2023 $137 · 2024 $211 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $178 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: FANAPT, ZENPEP, INGREZZA, Briviact, Qelbree.
Industry payments across ID — which companies pay providers there.
